Physician profile
Claudio A Lima
NPI 1285737858
$664.83
in general payments reported to CMS, 2019-2025
8 companies · $96.54 in 2025
The $96.54 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $43.85 · 2021: $69.02 · 2022: $24.67 · 2024: $292 · 2025: $96.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $456.33 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Medtronic, INC. | $46.04 | 2024 | Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $40.04 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.45 | 2020-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $24.92 | 2024 | Arcalyst |
| Boston Scientific Corporation | $24.67 | 2022 | |
| Abbott Laboratories | $19.71 | 2021 | |
| Vapotherm INC | $18.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudio Lima listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.